EUVIMEDEUVIMED entdecken
Crossref

JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice

Vanessa Zambelli, Laura Rizzi, Paolo Delvecchio, Elena Bresciani, Laura Molteni, Ramona Meanti, Verdiè Pascal, Jean-Alain Fehrentz, Robert J Omeljaniuk, Giacomo Bellani, Antonio Torsello

Pulmonary Pharmacology & Therapeutics · 2020-06 · 62 · 101916

DOI: 10.1016/j.pupt.2020.101916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pulmonary Pharmacology & Therapeutics, 2020-06. Verfasst von Vanessa Zambelli und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Università degli Studi di Milano-Bicocca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TLQP-21, a peptide encoded by the prohormone VGF, is expressed in neuroendocrine cells and can modulate inflammatory processes. Since TLQP-21 can bind the complement 3a receptor 1 on macrophages, interest has risen in this peptide as a potential drug for the treatment of Acute Respiratory Distress Syndrome (ARDS), whose hospital mortality can reach 35-46%. Since no effective pharmacologic therapies are available, our aim was to exploit the potential of a short analog of TLQP-21(JMV5656) in order to modulate the inflammatory process in ARDS and the progression to pulmonary fibrosis in an experimental model of unilateral acid aspiration in mice. Mice were divided in 2 treatment groups. In the acute protocol, mice received intra-peritoneal injection of either vehicle or 0.6 mg/kg JMV5656 on experimental days 1 and 2, and ARDS was induced on day 3 under deep anesthesia by instillation of HCl (1.5 ml/kg of 0.1 M HCl in 0.9% NaCl) into the right lung; all measurements were performed 24 h later. In the subacute protocol, mice were treated as previously, but treatment with vehicle or JMV5656 was repeated also on day 4 and measurements were made 2 weeks later. Twenty-four hours after acid instillation, the total number of immune cell in the BAL rose sharply due primarily to an increase in the PMN population which increased from 1% up to 58% of total cell numbers. JMV5656 significantly reduced PMN recruitment into the alveolar space, but had no effects on cytokine levels in BAL. Two weeks after acid injury, static compliance of the right lung was significantly higher in the JMV5656-treated group compared to vehicle-treated group. Treatment with JMV5656 also blunted the acid-induced collagen deposition in the right lung. These results suggest that JMV5656 can ameliorate mechanical compliance, and reduce collagen deposition in acid-injured lungs in mice. This effect was likely due to the ability of JMV5656 to inhibit PMN recruitment in the injured lung.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsBronchoalveolar LavageCytokinesLungLung InjuryMaleMiceMice, Inbred C57BLModels, AnimalPeptide FragmentsPulmonary FibrosisRespiratory Distress SyndromeSynthetic Drugs

Stichwörter der Autor:innen

ARDSInflammationJMV5656Lung fibrosisTLQP-21

Substanzen

CytokinesPeptide FragmentsSynthetic DrugsTLQP-21 peptide

Autor:innen und Institutionen

  • School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy. Electronic address: laura.rizzi@unimib.it.
  • Max Mousseron Institute of Biomolecules UMR5247, CNRS, University of Montpellier, ENSCM, Montpellier, France.
  • Department of Biology, Lakehead University, Thunder Bay, ON, Canada.

Förderung

  • Università degli Studi di Milano-Bicocca

Zitieren

APA

Zambelli, V., Rizzi, L., Delvecchio, P., Bresciani, E., Molteni, L., Meanti, R., Pascal, V., Fehrentz, J. A., Omeljaniuk, R. J., Bellani, G., & Torsello, A. (2020). JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice. Pulmonary Pharmacology & Therapeutics, 62, 101916. https://doi.org/10.1016/j.pupt.2020.101916

Vancouver

Zambelli V, Rizzi L, Delvecchio P, Bresciani E, Molteni L, Meanti R, et al. JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice. Pulmonary Pharmacology & Therapeutics. 2020;62:101916. doi:10.1016/j.pupt.2020.101916

BibTeX
@article{Zambelli2020,
  author = {Zambelli, Vanessa and Rizzi, Laura and Delvecchio, Paolo and Bresciani, Elena and Molteni, Laura and Meanti, Ramona and Pascal, Verdiè and Fehrentz, Jean-Alain and Omeljaniuk, Robert J and Bellani, Giacomo and Torsello, Antonio},
  title = {JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice},
  journal = {Pulmonary Pharmacology & Therapeutics},
  year = {2020},
  volume = {62},
  pages = {101916},
  doi = {10.1016/j.pupt.2020.101916}
}
Kostenlos starten →